Navigation Links
Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
Date:10/9/2008

CALGARY, Oct. 9 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the 16th Annual BioPartnering Europe conference in London, U.K. on Monday, October 13 at 2 p.m. The conference is taking place at the Queen Elizabeth II Conference Centre from October 12-14, 2008.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com

The presentation time is subject to change. This release and the presentation related thereto contain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control and which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or expectations implied by these forward-looking statements. Such risks and uncertainties include, among others, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Media Advisory - Oncolytics Biotech Inc. to Present at Maxim Group Growth Conference
2. Cell Therapeutics Provides Details on Investor & Media Day to be Held in Milan, Italy on Friday, October 3, 2008
3. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
4. U.S. News Media Group Releases 19th Edition of Americas Best Hospitals
5. VIDEO from Medialink and Med-El: New Technology is Music to Peoples Ears
6. BioLife Solutions Announces FDA Master File Acceptance for CryoStor(TM) Pre-formulated Cryopreservation Media
7. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
8. Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008
9. Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference
10. Intellisphere Announces Acquisition of Multiple Titles from Ascend Medias Healthcare Division
11. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., SHANGHAI, Nov. 9 /PRNewswire-Asia/ -- The p...n their evolution. The companies are facing signi... skyrocketing R&D costs, calls for,lower price...s together with,the financial crisis have made the...pharmaceutical companies are being forced to globa...
(Date:11/9/2009)..., VIENNA, Va., Nov. 9 C...day that Dr. Kenneth S. Rosenthal, Professor of Im...versities College of Medicine and Pharmacy, report...sts at the Cleveland Clinic and CEL-SCI on CEL-SCI...ed at the 7th GTCbio Vaccine: "All Things Consider...
(Date:11/9/2009)... Product release is a resear...bjects, research facilities and research safety st.... , Cedar Knolls, NJ (PRW...ounced today that it has unveiled Pristima™ ... research facilities that track the use and care o...
(Date:11/8/2009)...ovember 6, 2009 As global temperatures and energy...gy will be key to a sustainable future. An attra...two studies published online in Genome Research ...enome structures of bioethanol-producing microorga...cal in developing new technologies needed to imple...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in Shanghai 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2
...s Pharma, the,Danish biopharmaceutical company dev...at Keith McCullagh, President and Chief Executive,...pany and its goals for,2008 at the Biotechnology I...Conference in New York, today, Monday February 11t...ral European Time). The conference is,being held a...
...28, The Royal,Marsden Hospital (Sutton, Surrey, UK...lated Arc Therapy (VMAT)* treatment in the world u...e the treatment, the hospital,used its existing El...n,linear accelerator control system., (Logo: htt...GO ), VMAT takes Intensity Modulated Radiation T...
...0 Doses of the CDC,s National Strategic...OLIS, Feb. 11 Sentry Logistic Solutions,announced...ention (CDC),signed a contract to outsource storag...ve of the influenza virus vaccine. Sentry will war...ses from its pharmaceutical cold,chain logistics c...
Other Biology Technology:Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008 2Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital 2The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions 2The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions 3
(Date:11/5/2009)...hers (NABT) will recognize Leonard C. Yannielli, p...y Community College (NVCC) in Waterbury, Connectic... the NABT annual professional development conferen...ado. , The Evolution Education Award is cosponso...es,(AIBS) and Biological Sciences Curriculum Stud...
(Date:11/4/2009)...luctant to officially endorse green tea as a cance...out its protective effects, including results of a...h , a journal of the American Association for Canc... cancer. , Vassiliki Papadimitrakopoulo, M.D., ...c/Head and Neck Medical Oncology at the University...
(Date:11/4/2009)...od obesity in the United States is reaching epidem...tising on daytime and prime time television devote...about the role television plays in obesity, a stud...f Nutrition Education and Behavior examines how f... contributor to the problem. , Researchers at th...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 1Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 2Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 3VIVUS Reports Second Quarter 2009 Financial Results 54258 1VIVUS Reports Second Quarter 2009 Financial Results 54258 2VIVUS Reports Second Quarter 2009 Financial Results 54258 3VIVUS Reports Second Quarter 2009 Financial Results 54258 4VIVUS Reports Second Quarter 2009 Financial Results 54258 5VIVUS Reports Second Quarter 2009 Financial Results 54258 6VIVUS Reports Second Quarter 2009 Financial Results 54258 7Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 1Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 2
...r gene has been discovered by scientists at the Lu...tic Surgery Clinic at the Sahlgrenska Academy in S...tain hereditary deformity syndrome run a nearly tw...r than expected. , Several research teams around ...ary breast cancer genes, but thus far few have bee...
...ng Project, funded by the National Institute of Al...National Institutes of Health (NIH), announced tod...ire genetic blueprints of more than 2,000 human an...d the world have been completed and the sequence d...information will help scientists understand how in...
...of York have won a grant of £110,000 to investigat...sease. , Dr Jason Lynam and Dr Ian Fairlamb, of t... awarded the funding by the Leverhulme Trust for a...for the controlled release of carbon monoxide into...inflammatory, and they want to explore its potenti...
Other Biology News:New hereditary breast cancer gene discovered 22,000 influenza virus genomes now completed and publicly accessible 2Research to spotlight carbon monoxide benefits 2
GIBCO Improved MEM Zn++ Option (Richter's Modification) liquid from Invitrogen
GIBCO AlbuMAX I from Invitrogen
Chicken Anti-EEA1 Monoclonal Antibody, Unconjugated, Clone PADZMD.477 from Invitrogen
GIBCO Chemically Defined Lipid Concentrate from Invitrogen
Biology Products: